Last week, the US Senate unanimously approved SC Republican Jim DeMint’s amendment to the FDA reauthorization bill stating the agency must have risk assessment and solution strategies in place with the manufacturer of RU-486 within seven months after the bill takes effect.
The abortion industry, mindless of women’s health if it interferes with abortion, bulldozed FDA approval of RU-486 during the waning Clinton days in 2000 via an acceleration process supposed to be reserved for “life-threatening illnesses.”
Since its rush approval, RU-486 has been linked to the deaths of at least seven American women, most due to toxic shock syndrome from the deadly bactium Clostridium sordellii, which may be an emerging risk of using RU-486.
The much publicized death of 18-year-old Holly Patterson in 2003 from RU-486 should have moved the FDA to pull RU-486 off the market, but it did not. It merely added a list of risks to RU-486’s label.
The FDA has now received reports of 1,050 additional women who experienced adverse events from the RU-486 regimen including 9 life-threatening incidents, 232 hospitalizations, 116 blood transfusions, and 88 cases of infection, according to DeMint.
Pro-lifers warned about the risks of RU-486 when it was approved in a blatantly political decision back in 2000, but were shouted down in a cry of women’s rights. As my prior post showed, pro-abortionists don’t worry so much about unborn women’s right to life; we see here they don’t worry so much about born women’s right to life if it would impede the spread of free abortion.